Asia Green Biotechnology Corp.

As of September 30, 2024, Asia Green Biotechnology Corp. has 36.25M shares outstanding.

These figures are as of September 30, 2024. Asia Green Biotechnology Corp. trades at an EV/FCF ratio of 7.86, comparing the total takeover cost of the business to the cash it actually generates for all capital providers.

As of September 30, 2024, Asia Green Biotechnology Corp. maintains a current ratio of 0.01, meaning it holds 0.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -36.01, indicating conservative leverage, while an interest coverage ratio of -9.14 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended September 30, 2024. Return on assets (ROA) is negative at -1,036.38, reflecting losses generated across the asset base.

As of the close on March 5, 2024, Asia Green Biotechnology Corp.'s stock has declined approximately 40.00% over the past 52 weeks. The 50-day moving average sits at 0.01, while the 200-day moving average is 0.02.

These figures cover the twelve months ended September 30, 2024. Total shareholder yield is negative at -10.25, meaning Asia Green Biotechnology Corp. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of September 30, 2024, Asia Green Biotechnology Corp. has an Altman Z-Score of -877.65, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.